Computer technology for the accelerated discovery of drugs

A computer technology has been invented to accelerate drug discovery. It predicts locations in disease-associated biomolecules where drug molecules could bind, induce shape changes, and thereby bring the activity of the biomolecule under control.

A US drug discovery company, Serometrix, has exclusively licensed this technology and incorporated it within their core discovery process. 

The impact upon them has been:

  • A step change in their technical approach towards small molecule drug discovery
  • Attraction of $227k venture capital funding for the new company direction
  • Expansion of workforce (four new personnel by end of 2013)
  • "Shaving years off" their discovery development programme
  • Promising new drug leads
  • Planned reduction of early trial compounds "from millions to hundreds".

First published: 17 December 2013